FDA OKs Hologic's 3-D mammography exam

The Food and Drug Administration approved a labeling change to Hologic's Genius 3-D Mammography test.

The labeling change designates the 3-D mammogram as a more effective diagnostic test for women with dense breasts than 2-D mammograms.

"Radiologists and referring physicians needed an answer for how to screen the roughly half of women with dense breasts, because until now, this patient population was confused and frustrated without a clear path forward," Pete Valenti, division president of Hologic's Breast and Skeletal Health Solutions unit, said in a news release.

More articles on supply chain:

7 drugmakers in the headlines
4 ways hospitals can lower inpatient drug costs
6 must-reads for supply chain leaders this week

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers